AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glykind M 60mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Mankind Pharma Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Glykind M 60mg/500mg Tablet ER

Diabetic patients using the extended-release Glykind M 60mg/500mg tablet, an anti-diabetic medication, should understand its dual-action mechanism for managing type 2 diabetes in adults. This combined therapy effectively regulates blood glucose. Administer this medication with food, consistently at the same time daily, for optimal results. Dosage is determined and adjusted by your physician based on your blood sugar readings. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a holistic approach including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are paramount in diabetes control. Common side effects include hypoglycemia (characterized by sweating, dizziness, headache, and tremors), constipation, and nausea. Always carry a readily available glucose source (e.g., sugary snacks, fruit juice) to counteract hypoglycemia. Alcohol consumption should be limited due to its hypoglycemic risk. Other potential side effects are altered taste, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended under your physician's guidance.

Uses of Glykind M 60mg/500mg Tablet ER

Adult-onset diabetes

Major Benefits of Glykind M 60mg/500mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glykind M 60mg/500mg Extended-Release tablets should be taken with a meal.

Common Side effects of Glykind M 60mg/500mg Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glykind M 60mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glykind M 60mg/500mg Extended-Release Tablets. Ingest the tablets whole; do not crush, chew, or break them. Administer this medication with a meal.

How Glykind M 60mg/500mg Tablet ER works:

Extended-release Glykind M tablets (60mg/500mg) combine the antidiabetic agents gliclazide and metformin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glykind M 60mg/500mg Extended-Release Tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glykind M tablets (60mg/500mg) are contraindicated during pregnancy due to established fetal risks. In exceptional circumstances involving life-threatening conditions, a physician may prescribe them if the potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glykind M tablets (60mg/500mg) are likely unsuitable for breastfeeding mothers. Available evidence from humans indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glykind M 60mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glykind M 60mg/500mg Extended-Release tablets. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glykind M 60mg/500mg Extended-Release tablets cautiously. Dosage modification of Glykind M 60mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised. For those with mild to moderate hepatic dysfunction, Glykind M 60mg/500mg Extended-Release tablets are typically initiated at a reduced dose; however, its use is contraindicated in patients with severe liver disease.

What if you forget to take Glykind M 60mg/500mg Tablet ER :

Should you forget a Glykind M 60mg/500mg Extended-Release Tablet, administer it immediately upon recollection. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glykind M 60mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Glykind M 60mg/500mg Tablet ER

Glykind M 60mg/500mg Extended-Release tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glykind M is not suitable for type 1 diabetes.
Glykind M 60mg/500mg ER tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glykind M 60mg/500mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glykind M 60mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is linked to high blood lactic acid levels. To minimize risk, it's avoided in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glykind M 60mg/500mg Tablet ER and seek immediate medical attention.
Prolonged use of Glykind M 60mg/500mg Tablet ER can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glykind M 60mg/500mg Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Glykind M 60mg/500mg ER tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glykind M 60mg/500mg Extended-Release tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Glykind M 60mg/500mg Tablet ER commonly causes side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Glykind M 60mg/500mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glykind M 60mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glykind M 60mg/500mg Tablet ER and seek immediate medical attention.
Prolonged use of Glykind M 60mg/500mg Tablet ER can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended annually, as suggested by some researchers.
Glykind M 60mg/500mg Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Glykind M 60mg/500mg ER tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glykind M 60mg/500mg Tabl...
92
MRP 112
17% off